Cosciens Biopharma Inc.盘中异动股价大涨5.33%报3.16美元

市场透视11-14 01:02

北京时间2024年11月14日01时02分，Cosciens Biopharma Inc.（CSCI.us）股票出现异动，股价急速上涨5.33%。截至发稿，该股报3.16美元/股，成交量1227股，换手率0.04%，振幅2.33%。最近的财报数据显示，该股实现营业收入1.87百万美元，净利润-5.76百万美元，每股收益-1.85美元，毛利830000.00美元，市盈率-0.12倍。机构评级方面，...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2483831498?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-11-14 01:02","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2483831498","market":"us","top_or_hot":-1,"title":"Cosciens Biopharma Inc.盘中异动 股价大涨5.33%报3.16美元","media":"市场透视","content":"<div>\n<p>北京时间2024年11月14日01时02分，Cosciens Biopharma Inc.（CSCI.us）股票出现异动，股价急速上涨5.33%。截至发稿，该股报3.16美元/股，成交量1227股，换手率0.04%，振幅2.33%。最近的财报数据显示，该股实现营业收入1.87百万美元，净利润-5.76百万美元，每股收益-1.85美元，毛利830000.00美元，市盈率-0.12倍。机构评级方面，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114010208a234a872&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cosciens Biopharma Inc.盘中异动 股价大涨5.33%报3.16美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCosciens Biopharma Inc.盘中异动 股价大涨5.33%报3.16美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-14 01:02 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114010208a234a872&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年11月14日01时02分，Cosciens Biopharma Inc.（CSCI.us）股票出现异动，股价急速上涨5.33%。截至发稿，该股报3.16美元/股，成交量1227股，换手率0.04%，振幅2.33%。最近的财报数据显示，该股实现营业收入1.87百万美元，净利润-5.76百万美元，每股收益-1.85美元，毛利830000.00美元，市盈率-0.12倍。机构评级方面，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114010208a234a872&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CSCI","symbol_name":"COSCIENS Biopharma Inc","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114010208a234a872&s=b","article_id":"2483831498","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114010208a234a872&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2483831498","pubTimestamp":1731517328,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年11月14日01时02分，Cosciens Biopharma Inc.股票出现异动，股价急速上涨5.33%。截至发稿，该股报3.16美元/股，成交量1227股，换手率0.04%，振幅2.33%。Cosciens Biopharma Inc.股票所在的生物技术行业中，整体跌幅为0.19%。Cosciens Biopharma Inc.公司简介：依特钠有限公司是一家生物制药公司，为医疗保健和化妆品行业开发和商业化多元化的制药和诊断产品及活性成分组合。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"CSCI":"COSCIENS Biopharma Inc","BK4139":"生物科技"},"translate_title":"Cosciens Biopharma Inc. shares rose 5.33% to $3.16 in intraday changes","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CSCI":0.9},"content_text":"北京时间2024年11月14日01时02分，Cosciens Biopharma Inc.（CSCI.us）股票出现异动，股价急速上涨5.33%。截至发稿，该股报3.16美元/股，成交量1227股，换手率0.04%，振幅2.33%。最近的财报数据显示，该股实现营业收入1.87百万美元，净利润-5.76百万美元，每股收益-1.85美元，毛利830000.00美元，市盈率-0.12倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Cosciens Biopharma Inc.股票所在的生物技术行业中，整体跌幅为0.19%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028(To Pur Com)、Tc Biopharm (Holdings) Plc C/Wts 10/02/2028 (To Pur Ads)、Pulmatrix, Inc.涨幅较大，Cyclacel Pharmaceuticals, Inc.、Elevai Labs, Inc.、Calidi Biotherapeutics, Inc.较为活跃，换手率分别为492.46%、296.99%、117.78%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029(To Pur Com)、Calidi Biotherapeutics, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)，振幅分别为108.00%、67.77%、52.94%。Cosciens Biopharma Inc.公司简介：依特钠有限公司是一家生物制药公司，为医疗保健和化妆品行业开发和商业化多元化的制药和诊断产品及活性成分组合。该公司从事治疗资产和专有提取技术的开发。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2483831498"}

Cosciens Biopharma Inc.盘中异动 股价大涨5.33%报3.16美元

精彩评论

Cosciens Biopharma Inc.盘中异动股价大涨5.33%报3.16美元